RPL5 and lung carcinoma: Xie et al. found that silencing of RPL32 causes RPL5 and RPL11 to be transferred from the nucleus to the nucleoplasm, leading to the accumulation of p53 and inhibition of lung cancer proliferation (Xie et al., 2020).